The US Justice Department filed a civil fraud lawsuit against Swiss drug maker Novartis, accusing it of paying kickbacks in exchange for prescribing its drugs. Andrea Day explains in this NBR interview how the lawsuit came about and what’s at risk for the pharmaceutical giant.
Hosts
Top Stories from CNBC- Capitol Police probing claims GOP lawmakers gave tours to Trump supporters before riot
- Health Secretary Azar tells Trump U.S. Capitol attack was assault on democracy that tarnishes legacy
- These entrepreneurs want a second PPP loan. What you should know if you're applying for more money
- 'I don’t see anything on the horizon that can stop the growth of the ETF market,' Invesco official says. Here are her 2021 predictions
- Apple CEO Tim Cook's new cash bonus sweetener not tied to bigger sales or profits
